VIMOVO

Valsts: Izraēla

Valoda: angļu

Klimata pārmaiņas: Ministry of Health

Aktīvā sastāvdaļa:

ESOMEPRAZOLE AS MAGNESIUM TRIHYDRATE 20 MG; NAPROXEN 500 MG

Pieejams no:

ASTRA ZENECA ISRAEL LTD

ATĶ kods:

G02CC02

Zāļu forma:

TABLETS MODIFIED RELEASE

Ievadīšanas:

PER OS

Ražojis:

ASTRA ZENECA AB., SWEDEN

Ārstniecības grupa:

NAPROXEN

Ārstēšanas norādes:

Vimovo is a combination product that contains naproxen and esomeprazole. It is indicated for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis and to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers. Vimovo is not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen-containing products.

Autorizācija datums:

2011-12-01